SCHEMBL7457007

SCHEMBL7457007

NC(=O)c1cccnc1C(=O)NC1COC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.48
ALDH1A1 P00352 4/20 0.48
GAA P10253 1/20 0.48
PDE10A Q9Y233 1/20 0.45
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
PARP1 P09874 1/20 0.41
RAB9A P51151 2/20 0.40
GRM4 Q14833 1/20 0.40
ADORA2A P29274 1/20 0.40
ADORA2B P29275 1/20 0.40
HTR3A P46098 4/20 0.40
CYP3A4 P08684 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KMT2A Q03164 1/20 0.40
P2RX7 Q99572 1/20 0.39
TGFBR1 P36897 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9206481 0.87 ALDH1A1 (0.58) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL9207132 0.83 ALDH1A1 (0.69) KDM4EALDH1A1GAAHPGDRAB9A
SCHEMBL9207305 0.83 ALDH1A1 (0.69) KDM4EALDH1A1GAAHPGDRAB9A
SCHEMBL7457012 0.83 GRM4 (0.53) KDM4EALDH1A1GAAPDE10AGRM4
SCHEMBL3720002 0.81 EGLN2 (0.50) KDM4EALDH1A1GAAPDE10AGRM4
SCHEMBL26856718 0.77 ADORA2A (0.46) KDM4EALDH1A1GAAPDE10AGRM4
SCHEMBL5902495 0.76 PARP1 (0.50) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL7452418 0.74 KDM4E (0.49) KDM4EALDH1A1HPGDHSD17B10PARP1
SCHEMBL15402517 0.73 PDE10A (0.47) KDM4EALDH1A1PDE10AHPGDHSD17B10
SCHEMBL773980 0.73 PARP1 (0.58) KDM4EALDH1A1HPGDHSD17B10PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP claimed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US claimed
US-8623866-B2 2014-01-07 US claimed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US claimed
EP-2580207-B1 NITROGEN CONTAINING HETEROARYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2017-09-27 EP disclosed
US-8703768-B2 Nitrogen containing heteroaryl compounds HOFFMANN-LA ROCHE INC. (US) 2014-04-22 US disclosed
US-8623866-B2 2014-01-07 US disclosed
EP-2580207-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. Hoffmann-La Roche AG (CH) 2013-04-17 EP disclosed
WO-2011154327-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 WO disclosed
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2011-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110306589-A1 NITROGEN CONTAINING HETEROARYL COMPOUNDS PDE10A, PDE3A, PDE2A KDM4E 2322/4885ALDH1A1 271/4885GAA 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.